Sender: |
|
Date: |
Mon, 22 Sep 2003 08:15:28 EDT |
Reply-To: |
|
Subject: |
|
MIME-Version: |
1.0 |
Content-Transfer-Encoding: |
7bit |
Content-Type: |
text/plain; charset="US-ASCII" |
From: |
|
Comments: |
|
Parts/Attachments: |
|
|
In a message dated 9/19/03 9:47:00 PM Pacific Daylight Time,
[log in to unmask] writes:
> Dr. Hale book shows L3 category, but this was on a study of 2 infants (3
> weeks old). Can I assume it would be less risky on this minimal nursing 14
> month
> old?
>
Loretta, I have noticed others use Dr. Hale's term L3 category as a basis of
concern for a medication and I wanted to only point out that this is a general
guideline not a definitive "risk when breastfeeding".
L3 Moderately Safe: There are no controlled studies in breastfeeding women,
however the risk of untoward effects to a breastfed infant is possible; or,
controlled studies show only minimal non-threatening adverse effects. Drugs
should be given only if the potential benefit justifies the potential risk to the
infant. (from Medications and Mothers' Milk)
I think you are on the right track when you state that this is a 14 month old
who only nurses twice a day.
Ann Perry RN IBCLC
Boston, MA
***********************************************
To temporarily stop your subscription: set lactnet nomail
To start it again: set lactnet mail (or digest)
To unsubscribe: unsubscribe lactnet
All commands go to [log in to unmask]
The LACTNET mailing list is powered by L-Soft's renowned
LISTSERV(R) list management software together with L-Soft's LSMTP(TM)
mailer for lightning fast mail delivery. For more information, go to:
http://www.lsoft.com/LISTSERV-powered.html
|
|
|